CN109839463A - A kind of preparation of Cortex Moutan Dispersing Granules primary standard substance and method of quality control - Google Patents
A kind of preparation of Cortex Moutan Dispersing Granules primary standard substance and method of quality control Download PDFInfo
- Publication number
- CN109839463A CN109839463A CN201910263819.XA CN201910263819A CN109839463A CN 109839463 A CN109839463 A CN 109839463A CN 201910263819 A CN201910263819 A CN 201910263819A CN 109839463 A CN109839463 A CN 109839463A
- Authority
- CN
- China
- Prior art keywords
- cortex moutan
- dispersing granules
- primary standard
- standard substance
- quality control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of preparation of Cortex Moutan Dispersing Granules primary standard substance and method of quality control; using cortex moutan medicine materical crude slice as raw material; by water decoct twice, be concentrated under reduced pressure, Cortex Moutan Dispersing Granules primary standard substance is made in the process flows such as dry, global quality control is carried out using high performance liquid chromatography.The present invention is on the basis of motherland's Chinese Traditional Medicine decoction, in conjunction with modern times freeze-drying, diaphragm vacuum and low temperature concentration high technology equipment, pharmaceutical technology and high-efficient liquid phase chromatogram technology, and refer to cortex moutan chemical constitution study, the research of family's decocting process, the research of HPLC characteristic spectrum are carried out to cortex moutan, obtain a kind of reference substance that can be used as Cortex Moutan Dispersing Granules and arrange quality control.The substance can help to realize full constituents extraction, Manufacturing science, quality controllable, and cortex moutan Chinese medicinal granule and family that large-scale production may be implemented decoct the Appreciation gist of curative effect consistency, guarantee Chinese medicinal granule quality.The substance has preparation simply, and health is convenient for storage.
Description
Technical field
The present invention relates to traditional Chinese medicine product technical field more particularly to a kind of preparations of Cortex Moutan Dispersing Granules primary standard substance
And method of quality control.
Background technique
Cortex moutan, it is bitter in taste, pungent, slightly cold, there is the effect of clearing heat and cooling blood, activating microcirculation and removing stasis medicinal, enter ying blood, epidemic heat syndrome hair for heat
Spot, hematemesis and epistaxis, night fever abating at dawn, lossless hectic fever due to yin, amenorrhea and algomenorrhea, the pain of injury caused by falling and tumbling, carbuncle sore tumefacting virus.
Cortex moutan is used as medicine with medicine materical crude slice, and the mode of decoction taken, The Quality of Sliced Herbal Medicine are unstable not before use
Controllably, it decocts quality to be difficult to ensure, takes inconvenience, be not easy to store.And Chinese medicinal granule is to meet the excellent of concocted specification
Matter medicinal material (prepared slices of Chinese crude drugs) is raw material, is extracted, is concentrated using modern high technology, product system class made of granulation, guaranteed original
The nature and flavor feature of Chinese medicine.But how to guarantee quality of the Cortex Moutan Dispersing Granules in the case where losing medicine materical crude slice appearance character and with family
Front yard decocts the consistency of curative effect, and there is presently no a reasonable controls, so the method that we imitate family's decoction, use are cold
The method that the concentration of dry and diaphragm vacuum and low temperature is lyophilized prepares Cortex Moutan Dispersing Granules primary standard substance, is established with high performance liquid chromatography
Its HPLC characteristic spectrum arranges the reference of quality control as Cortex Moutan Dispersing Granules.
Summary of the invention
The object of the invention is to remedy the disadvantages of known techniques, provides a kind of Cortex Moutan Dispersing Granules primary standard substance
Preparation and method of quality control.
The present invention is achieved by the following technical solutions:
A kind of preparation method of Cortex Moutan Dispersing Granules primary standard substance, the preparation of the Cortex Moutan Dispersing Granules primary standard substance are adopted
It is made with freeze-drying with the method that the concentration of diaphragm vacuum and low temperature combines.
The preparation method of the Cortex Moutan Dispersing Granules primary standard substance, specifically includes the following steps:
(1) cortex moutan medicine materical crude slice is weighed, first decocts the water for adding 8-10 times of medicine materical crude slice amount to measure, and first impregnates 30min, is cooked by slow fire again after boiling
30min filters to isolate decoction liquor while hot, and the second pan-fried plus 6-8 times amount water decocts 30min, filters, merging decoction liquor, mixing,
Steam-volatile oil 2 hours, distillate is collected, it is spare;
(2) step 1 gained medical fluid is taken, vacuum degree -0.090-0.099 is adjusted, is concentrated into the clear of 1.07-1.09 at 65 DEG C or less
Cream, it is spare;
(3) step 2 gained clear cream is placed in the stainless steel disc of certain specification, is placed in freeze drier, closed door-plate and open
Refrigeration waits baffle temperature to be down to target temperature, transfers the program of formula access, opens vacuum pump, temperature control and formula and opens
It closes, is freeze-dried, after freeze-drying, close vacuum pump, open vent valve, pump pressure reaches normal pressure, closes refrigeration, fast
Speed opens door-plate, collects sample, sealing.
It is kept for 8 hours in the freezing dry process prior to -45 DEG C, is kept for 4 hours then at -30 DEG C, kept then at -10 DEG C
It 3.5 hours, keeps then at 20 DEG C 3 hours, is finally kept for 30 hours in 50 DEG C.
The present invention also provides a kind of method of quality control of Cortex Moutan Dispersing Granules primary standard substance, and quality control is using high
Effect liquid phase chromatogram method establishes the HPLC characteristic spectrum of Cortex Moutan Dispersing Granules primary standard substance.
The method of quality control, comprising the following steps:
(1) this product powder 0.2g is taken, it is accurately weighed respectively, it sets in 25ml measuring bottle, methanol 20ml, ultrasonic 30min is added, standing is put
Cold, constant volume, filtering, filtrate is as test sample;
(2) Paeoniflorin 0.6mg is taken, is placed in 10ml volumetric flask, scale is dissolved and be settled to methanol, as object of reference;Take pellet
Skin phenol 1.0mg, is placed in 10ml volumetric flask, scale is dissolved and be settled to methanol, as object of reference;
(3) it is tested using high performance liquid chromatography, it is accurate respectively to draw test solution, contrast solution 5-10 μ l, inject chromatography
Instrument is measured according to following chromatographic condition:
Using octadecylsilane chemically bonded silica as filler;Mobile phase presses mobile phase binary gradient elutes:
Time (min) | Acetonitrile (%) | 0.1% formic acid water (%) |
0 | 7 | 93 |
10 | 16 | 84 |
10.01 | 17 | 83 |
30 | 20 | 80 |
60 | 35 | 65 |
70 | 65 | 35 |
80 | 80 | 20 |
Flow velocity: 1.0ml/min;Column temperature: 30 DEG C;Detection wavelength: 254nm;Number of theoretical plate should be not less than by the calculating of Paeonol peak
5000;
(4) by step 3 measurement result, analysis comparison is carried out, establishes the HPLC characteristic spectrum of Cortex Moutan Dispersing Granules primary standard substance.
The invention has the advantages that
High-tech is concentrated on the basis of motherland's Chinese Traditional Medicine decoction, in conjunction with modern times freeze-drying, diaphragm vacuum and low temperature in the present invention
Skill equipment, pharmaceutical technology and high-efficient liquid phase chromatogram technology, and cortex moutan chemical constitution study is referred to, family is carried out to cortex moutan and is decocted
Technical study, the research of HPLC characteristic spectrum are boiled, a kind of reference that can be used as Cortex Moutan Dispersing Granules and arrange quality control is obtained
Substance.The substance can help to realize full constituents extraction, Manufacturing science, quality controllable, and the tree peony of large-scale production may be implemented
Skin Chinese medicinal granule and family decoct the Appreciation gist of curative effect consistency, guarantee Chinese medicinal granule quality.The substance has
Preparation is simple, and health is convenient for storage.
Detailed description of the invention
Fig. 1 show Cortex Moutan Dispersing Granules primary standard substance HPLC characteristic spectrum.
Specific embodiment
Below in conjunction with specific example, technical scheme is described further:
Embodiment 1
The preparation of cortex moutan primary standard substance granule:
(1) raw material is weighed: cortex moutan medicine materical crude slice 3400g;
(2) cortex moutan medicine materical crude slice is put into cooking pot for herbs, decocted twice, added 9 times of medicine materical crude slice amount of water for the first time, impregnate 30 minutes, decoct
30 minutes, second plus 7 times of water of medicine materical crude slice amount, decoct 30 minutes, and medical fluid filtration, filtrate merges, and steam-volatile oil 2 is small
When, distillate is collected, it is spare;Medical fluid is pumped into concentration tank, is concentrated (vacuum degree -0.090-0.099MPa), is concentrated into relatively close
Degree be 1.07-1.09(65 DEG C) clear cream, it is spare;
(3) step 2 gained clear cream is placed in the stainless steel disc of certain specification, is placed in freeze drier, closed door-plate and open
Refrigeration waits baffle temperature to be down to target temperature.The program of formula access is transferred, vacuum pump, temperature control and formula is opened and opens
It closes, is freeze-dried, concrete operations are shown in Table 1:
The design of 1 lyophilisation condition of table
Segment number | Target temperature DEG C | Hour | Minute | Control |
1 | -45 | 8 | 0 | 0 |
2 | -30 | 4 | 0 | 30 |
3 | -10 | 3 | 30 | 10 |
4 | 20 | 3 | 0 | 10 |
5 | 50 | 30 | 0 | 10 |
Freeze-drying terminates, and closes vacuum pump, opens vent valve, and pump pressure reaches normal pressure, closes refrigeration, opens door-plate rapidly, receives
Collect sample, sealing;
(4) step 3 gained dried cream powder is crushed, crosses 80 meshes;It is first packed with 10 grams of polyethylene, then packed with 50 grams of full aluminium bags
(50g/ bags of loading amount) is to get finished product.
Embodiment 2
The method of quality control of Cortex Moutan Dispersing Granules primary standard substance HPLC characteristic spectrum:
(1) this product powder, medicinal powder, medicine materical crude slice powder 0.2g are taken, it is accurately weighed respectively, it sets in 25ml measuring bottle, methanol is added
20ml, ultrasonic 30min, standing are let cool, constant volume, and filtering, filtrate is as test sample;
(2) Paeoniflorin 0.6mg is taken, is placed in 10ml volumetric flask, scale is dissolved and be settled to methanol, as object of reference;Take pellet
Skin phenol 1.0mg, is placed in 10ml volumetric flask, scale is dissolved and be settled to methanol, as object of reference;
(3) accurate respectively to draw for examination referring to four 0512 high performance liquid chromatography of the general rule tests of " Chinese Pharmacopoeia " version in 2015
Product solution, contrast solution 5-10 μ l, injecting chromatograph are measured according to following chromatographic condition;
Using octadecylsilane chemically bonded silica as filler;Mobile phase presses mobile phase binary gradient elutes (such as table 2);Flow velocity:
1.0ml/min;Column temperature: 30 DEG C;Detection wavelength: 254nm;Number of theoretical plate is calculated by Paeonol peak should be not less than 5000;
2 mobile phase elution requirement of table
Time (min) | Acetonitrile (%) | 0.1% formic acid water (%) |
0 | 7 | 93 |
10 | 16 | 84 |
10.01 | 17 | 83 |
30 | 20 | 80 |
60 | 35 | 65 |
70 | 65 | 35 |
80 | 80 | 20 |
(4) by step 3 measurement result, carry out analysis comparison, with the HPLC characteristic spectrum of Cortex Moutan Dispersing Granules primary standard substance into
Row control.
As shown in Figure 1, showing to contain cortex moutan ingredient in test sample.
Embodiment 3
Moisture, extract and assay measurement in Cortex Moutan Dispersing Granules primary standard substance:
To moisture, extract and assay in the Cortex Moutan Dispersing Granules primary standard substance of 3 batches prepared in aforementioned manners
It is detected.Moisture is detected according to a conventional method.Determination of extractives is according to the hot dipping under ethanol soluble extractives measuring method item
(four general rules 2201 of " Chinese Pharmacopoeia " version in 2015) measurement, uses ethanol as solvent.Assay is according to (" Chinese Pharmacopoeia " 2015
Year version one) measuring method under cortex moutan item.Every inspection result is as shown in table 3, shows that indices comply with standard.
The every testing result of table 3
Lot number | Moisture (%) | Extract (%) | Paeonol content (%) |
1 | 4.5 | 65.53 | 3.22 |
2 | 4.7 | 63.41 | 3.00 |
3 | 4.2 | 60.80 | 4.04 |
Claims (5)
1. a kind of preparation method of Cortex Moutan Dispersing Granules primary standard substance, which is characterized in that the Cortex Moutan Dispersing Granules benchmark
The preparation of substance is made using freeze-drying with the method that the concentration of diaphragm vacuum and low temperature combines.
2. the preparation method of Cortex Moutan Dispersing Granules primary standard substance according to claim 1, which is characterized in that specifically include
Following steps:
(1) cortex moutan medicine materical crude slice is weighed, first decocts the water for adding 8-10 times of medicine materical crude slice amount to measure, and first impregnates 30min, is cooked by slow fire again after boiling
30min filters to isolate decoction liquor while hot, and the second pan-fried plus 6-8 times amount water decocts 30min, filters, merging decoction liquor, mixing,
Steam-volatile oil 2 hours, distillate is collected, it is spare;
(2) step 1 gained medical fluid is taken, vacuum degree -0.090-0.099 is adjusted, is concentrated into the clear of 1.07-1.09 at 65 DEG C or less
Cream, it is spare;
(3) step 2 gained clear cream is placed in the stainless steel disc of certain specification, is placed in freeze drier, closed door-plate and open
Refrigeration waits baffle temperature to be down to target temperature, transfers the program of formula access, opens vacuum pump, temperature control and formula and opens
It closes, is freeze-dried, after freeze-drying, close vacuum pump, open vent valve, pump pressure reaches normal pressure, closes refrigeration, fast
Speed opens door-plate, collects sample, sealing.
3. according to claim 1 or the preparation method of 2 described in any item Cortex Moutan Dispersing Granules primary standard substances, feature exist
In, it is kept for 8 hours in the freezing dry process prior to -45 DEG C, is kept for 4 hours then at -30 DEG C, it is small then at -10 DEG C of holdings 3.5
When, it keeps then at 20 DEG C 3 hours, is finally kept for 30 hours in 50 DEG C.
4. a kind of method of quality control of Cortex Moutan Dispersing Granules primary standard substance, which is characterized in that quality control uses efficient liquid
Phase chromatography establishes the HPLC characteristic spectrum of Cortex Moutan Dispersing Granules primary standard substance.
5. method of quality control according to claim 4, which comprises the following steps:
(1) this product powder 0.2g is taken, it is accurately weighed respectively, it sets in 25ml measuring bottle, methanol 20ml, ultrasonic 30min is added, standing is put
Cold, constant volume, filtering, filtrate is as test sample;
(2) Paeoniflorin 0.6mg is taken, is placed in 10ml volumetric flask, scale is dissolved and be settled to methanol, as object of reference;Take pellet
Skin phenol 1.0mg, is placed in 10ml volumetric flask, scale is dissolved and be settled to methanol, as object of reference;
(3) it is tested using high performance liquid chromatography, it is accurate respectively to draw test solution, contrast solution 5-10 μ l, inject chromatography
Instrument is measured according to following chromatographic condition:
Using octadecylsilane chemically bonded silica as filler;Mobile phase presses mobile phase binary gradient elutes:
Flow velocity: 1.0ml/min;Column temperature: 30 DEG C;Detection wavelength: 254nm;Number of theoretical plate should be not less than by the calculating of Paeonol peak
5000;
(4) by step 3 measurement result, analysis comparison is carried out, establishes the HPLC characteristic spectrum of Cortex Moutan Dispersing Granules primary standard substance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910263819.XA CN109839463A (en) | 2019-04-03 | 2019-04-03 | A kind of preparation of Cortex Moutan Dispersing Granules primary standard substance and method of quality control |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910263819.XA CN109839463A (en) | 2019-04-03 | 2019-04-03 | A kind of preparation of Cortex Moutan Dispersing Granules primary standard substance and method of quality control |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109839463A true CN109839463A (en) | 2019-06-04 |
Family
ID=66886712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910263819.XA Withdrawn CN109839463A (en) | 2019-04-03 | 2019-04-03 | A kind of preparation of Cortex Moutan Dispersing Granules primary standard substance and method of quality control |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109839463A (en) |
-
2019
- 2019-04-03 CN CN201910263819.XA patent/CN109839463A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101850070B (en) | Detection method for Chinese medicament Tangcao tablets | |
CN103381217B (en) | A kind of Liuweibuxue capsule and method of quality control thereof and application | |
CN109342631B (en) | Method for constructing HPLC fingerprint of Chinese medicinal composition and method for detecting quality of Chinese medicinal composition | |
CN102590433B (en) | A kind of quality determining method of the smooth preparation of liver | |
CN108226321B (en) | Fingerprint detection method and fingerprint of fructus piperis longi and fructus piperis longi stomach-ache granules | |
CN104391072A (en) | Quality control method of traditional Chinese medicine compound preparation for treating osteoporosis | |
CN102579734B (en) | Traditional Chinese medicine composition of bone healing medicine, preparing method thereof and detecting method thereof | |
CN113759045B (en) | Characteristic spectrum of notopterygium root decoction pieces or formula granules, construction method of characteristic spectrum, notopterygium root formula granules, preparation method of notopterygium root formula granules and quality control method of notopterygium root formula granules | |
CN113156019A (en) | Method for detecting multi-component content of liquorice heart-fire-purging decoction | |
CN1969958A (en) | Quality control method of an oral formulation for treating viral hepatitis | |
CN104483402A (en) | Quality inspection method of anti-hysteritis soft capsules | |
CN102778529B (en) | Method for testing quality of tibetan medicine composition Liuwei Datuoyeyunshi preparation | |
CN1311812C (en) | Preparation method of granular agent for raising leucocyte and its quality control method | |
CN103487548A (en) | Method for detecting Jinma Gantai preparation for treating hepatitis | |
CN103211907A (en) | Siwu decoction formulated particles, and preparation method and detection method thereof | |
CN110464825A (en) | A kind of dihuang drink pharmaceutical composition, preparation method, detection method | |
CN114252518B (en) | Establishment method of classical famous-prescription cortex mori Shang Wuzhi reference fingerprint and fingerprint thereof | |
CN103267824B (en) | Method for detecting wind-cold cold granules | |
CN109839463A (en) | A kind of preparation of Cortex Moutan Dispersing Granules primary standard substance and method of quality control | |
CN114848693A (en) | Wine-washed angelica sinensis decoction pieces and processing method, quality detection method and application thereof | |
CN107607653A (en) | The method for determining Radix Scrophulariae extract finger-print | |
CN109580865B (en) | Quality control method of cyclocarya paliurus | |
CN112763639A (en) | Preparation process and quality control method of radix Acanthopanacis Senticosi reference extract | |
CN103115976A (en) | Method for measuring content of in-blood chemical component-allantoin in medicinal material-psammosilene tunicoides | |
CN110007020A (en) | A kind of preparation of white peony root dispensing granule primary standard substance and method of quality control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190604 |
|
WW01 | Invention patent application withdrawn after publication |